Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish the most recent Medicines and Healthcare products Regulatory Agency (MHRA) pharmacovigilance assessment or signal evaluation report that specifically addresses potential cancer/neoplasm signals in relation to COVID-19 vaccines.

The Medicines and Healthcare products Regulatory Agency (MHRA) has not performed a signal assessment of ‘potential cancer/neoplasm’ in relation to COVID-19 vaccines authorised for use in the United Kingdom as there have not been any signals of this nature. The MHRA keeps emerging safety information under close review and will take appropriate actions should any new safety concerns be confirmed, communicating to healthcare professionals and the public as appropriate.